Clinical Edge Journal Scan

Incidence of dementia appears to be declining over time in patients with RA


 

Key clinical point: The risk for dementia in patients with rheumatoid arthritis (RA) appears to be decreasing over time even when compared with non-RA referents.

Major finding: The 10-year cumulative incidence of ADRD for incident RA in the 1980s, 1990s and 2000s was 12.7%, 7.2% and 6.2%, respectively. Overall risk for ADRD was higher among patients with RA vs non-RA referents (HR, 1.37; 95% CI, 1.04-1.81), but this gap narrowed over time, with ADRD risk being higher in patients diagnosed with RA vs referents in the 1990s (HR, 1.72; 95% CI, 1.09-2.70) but not in the 2000s (HR, 0.86; 95% CI, 0.51-1.45).

Study details: The data come from a retrospective, population-based cohort study involving 897 patients with RA diagnosed between 1980 and 2009 and matched with 885 non-RA referents.

Disclosures: This study was supported by grants from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Disease and National Institute of Aging . No conflicts of interest were reported.

Source: Kronzer VL et al. Semin Arthritis Rheum. 2021 Jun 15 . doi: 10.1016/j.semarthrit.2021.06.003 .

Recommended Reading

Commentary: RA August 2021
MDedge Rheumatology
RA: No significant change in efficacy and safety after adalimumab to CT-P17 switch
MDedge Rheumatology
Bazedoxifene effectively prevents glucocorticoid-induced bone loss in RA
MDedge Rheumatology
RA: Systemic glucocorticoids most beneficial for pain reduction shortly after initiation
MDedge Rheumatology
Sarilumab shows long-term promise in RA refractory to TNF inhibitors
MDedge Rheumatology
RA: Lower swollen joint count at 5 years is a predictor of unacceptable pain
MDedge Rheumatology
Screening for sarcopenia warranted in middle-aged and older adults with RA
MDedge Rheumatology
Radiological progression persists despite limited radiological damage in RA patients treated to target of remission
MDedge Rheumatology
RA: IL-6i with or without T-cell inhibitors lowers T2DM risk
MDedge Rheumatology
Risk factors for VTE and ASCVD in patients with RA
MDedge Rheumatology